Heard On The Street: Dealers Spot Action In Tata Chemicals, BHEL, PG Electroplast And More

NDTV Profit India has been tracking the action in the top dealing rooms of India’s financial capital, and this edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Tata Chemicals, BHEL, Elgi Equipments, Samvardhana Motherson and PG Electroplast.

Heard On The Street provides readers with what well-informed investors, especially HNIs, FIIs, DIIs, and mutual funds, are buying and selling in the stock market. It also tracks the latest unconfirmed/unverified chatter around stocks and/or sectors.

NDTV Profit picked up the following cues from the dealing room chatter during trade:

Tata Chemical

Dealers indicate that there are strong buy flows on the domestic institutional desk for Tata Chemicals. The delivery volumes are expected to be on the higher side.

BHEL and Elgi Equipment

Smart investors have been showing buying interest for both these counters. Buying interest in Elgi is in anticipation of strong earnings.

Samvardhana Motherson

The auto ancillary company is seeing sell flows on the foreign institutional desk ahead of Q4 earnings. The stock opened higher after the company said it will consider a bonus issue along with earnings in the board meeting. However, it failed to hold on to the gains.

PG Electroplast

The block deal where promoters of the company had offloaded a 5.6% stake has received strong demand, as per dealers. Multiple domestic mutual funds and AMCs have bid for the stake. Some of the major names include GIC (investment arm of the Singapore Govt.), Axis MF, Kotak MF and DSP.

Disclaimer: The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.